Birmingham: A study led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit to some patients hospitalised with COVID-19 pneumonia. The research has been published in the ‘The Lancet Respiratory Medicine Journal’.The CATALYST trial-tested UK-based biopharmaceutical company Izana Bioscience’s namilumab (IZN-101) as a potential […]